← FDA DRUG APPROVALS

FDA ANDA · ANDA075067

CROMOLYN SODIUM

Sponsor: ACTAVIS MID ATLANTIC

APPLICATION
ANDA075067
TYPE
ANDA
ORIGINAL APPROVAL
1999-07-19
LATEST ACTION
2005-01-06
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CROMOLYN SODIUMDiscontinued
CROMOLYN SODIUM 10MG/ML · SOLUTION · INHALATION

Approval history

2005-01-06Labeling · Supplement 6AP
2002-02-20Manufacturing (CMC) · Supplement 4AP
2001-04-03Manufacturing (CMC) · Supplement 3AP
2000-03-28Manufacturing (CMC) · Supplement 2AP
2000-03-28Manufacturing (CMC) · Supplement 1AP
1999-07-19OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →